Authors: GOODKIN DE KINKEL RP WEINSTOCKGUTTMAN B MEDENDORP SV SECIC M GOGOL D PERRYMAN JE UCCELLI MM NEILLEY L

Citation: De. Goodkin et al., A PHASE-II STUDY OF IV-METHYLPREDNISOLONE IN SECONDARY-PROGRESSIVE MULTIPLE-SCLEROSIS, Neurology, 51(1), 1998, pp. 239-245

Authors: ROONEY W GOODKIN D VERMATHEN M NEILLEY L WEINER M

Citation: W. Rooney et al., TEMPORAL RELATIONSHIP BETWEEN GD ENHANCEMENT AND REDUCED MTR IN MS LESIONS, Neurology, 48(3), 1997, pp. 5085-5085

Authors: MOHR DC NEILLEY L GATTO N GRIFFIN C LIKOSKY W STIEBELING B GOODKIN DE

Citation: Dc. Mohr et al., EXPECTATIONS OF MULTIPLE-SCLEROSIS PATIENTS INITIATING BETASERON THERAPY, Neurology, 45(4), 1995, pp. 197-197